Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Solid Tumors

Explore clinical trials studying Advanced or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

53 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Solid Tumors trial results

Active, not recruiting

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

NCT05382325

Conditions
Advanced or Metastatic Solid Tumors, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • Sanford Cancer Center ( Site 0005) Sioux Falls, South Dakota, United States
  • NEXT Oncology ( Site 0001) San Antonio, Texas, United States
  • Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0011) Toronto, Ontario, Canada
  • Rambam Health Care Campus-Oncology ( Site 0021) Haifa, Israel
View Trial Details
Active, not recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, not recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT05787587

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 27 locations
View Trial Details
Active, not recruiting

This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors.

NCT06074497

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
  • Peninsula & South Eastern Haematology and Oncology Group Frankston, Victoria, Australia
View Trial Details
Active, not recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, not recruiting

A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma

NCT06939283

Conditions
Advanced or Metastatic Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
View Trial Details
Active, not recruiting

A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors

NCT05399654

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • University of Southern California (USC) Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Sarah Cannon Research Institute (SCRI)- Denver Denver, Colorado, United States
  • AdventHealth Cancer Institute Orlando, Florida, United States
View Trial Details
Completed

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

NCT04670679

Conditions
Advanced or Metastatic Solid Tumors, Carcinoma, Carcinoma, Squamous Cell, +33 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 14 locations
View Trial Details

Related conditions